Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, et al. Breast Cancer Res Treat 2020 May 6. pii: 10.1007/s10549-020-05603.

Read + Share

Amedeo Smart

Independent Medical Education

O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, et al. Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat 2020 May 6. pii: 10.1007/s10549-020-05603.
PMID: 32378051